Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Manufacturing Times.
Press releases published on June 2, 2025
RBC iShares Expands iShares Core Offering with Launch of New ETFs
GlobeNewswire
·
June 2, 2025
TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Today, RBC iShares expands its iShares Core exchange traded fund (ETF) lineup with the launch of two iShares ETFs (each an ‘iShares Fund’ and collectively, the ‘iShares Funds’). The iShares Core S…
PONY AI Inc. Reaches Strategic Partnership with Xihu Group for Robotaxi Deployment in Shenzhen
GlobeNewswire
·
June 2, 2025
SHENZHEN, China, June 02, 2025 (GLOBE NEWSWIRE) -- Pony AI Inc. (“Pony.ai” or the “Company”) (Nasdaq: PONY), a global leader in achieving large-scale commercialization of autonomous mobility, today announced a strategic partnership with Shenzhen Xihu …
XRP Settlement Spurs Cloud Mining Innovation – JA Mining Introduces Mining Utility for Token Holders
GlobeNewswire
·
June 2, 2025
Image by JA Mining WARWICK, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- XRP has recently gained renewed momentum in the cryptocurrency space, with its price reaching a high of $3.39 in early 2025. Developments in Ripple’s legal proceedings have …
The Evolution of the CFO: From Financial Steward to Strategic Visionary
GlobeNewswire
·
June 2, 2025
Change is afoot, but that’s a good thing Gone are the days when CFOs merely managed balance sheets and ensured fiscal discipline. Today’s CFO is a dynamic strategist at the heart of shaping business direction and fueling growth. Beyond budget oversight …
Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
GlobeNewswire
·
June 2, 2025
Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE WYOST® (denosumab-bbdz) and Jubbonti® (denosumab-bbdz) are first and only FDA-approved interchangeable denosumab biosimilars available in US Improves access for patients …
One in Every Four New Enterprise Clients in H1 2025 Switched From Global CXM Vendors to Lucidya
GlobeNewswire
·
June 2, 2025
RIYADH, Saudi Arabia, June 02, 2025 (GLOBE NEWSWIRE) -- Lucidya, the region’s leading AI Customer Experience Management (CXM) platform, announced that one in every four new enterprise clients in H1 2025 made the switch from global CXM vendors. This …
PAIRMiner offre une prime de cloud mining de 150 $, alors que les avoirs institutionnels en Bitcoin battent des records
GlobeNewswire
·
June 2, 2025
Alors que les investissements institutionnels dans le Bitcoin atteignent des sommets, PAIRMiner lance une offre gratuite de cloud mining pour faciliter l’accès du grand public aux cryptomonnaies . Image par PAIRMiner LOS ANGELES, 02 juin 2025 (GLOBE …
PAIRMiner macht Bitcoin-Mining angesichts des Marktbooms zugänglicher
GlobeNewswire
·
June 2, 2025
Bild von PAIRMiner STUTTGART, Deutschland, June 02, 2025 (GLOBE NEWSWIRE) -- Da die Bitcoin-Preise wichtige Widerstandsniveaus überwinden, nimmt das Interesse der Anleger an digitalen Vermögenswerten erneut zu. Die cloudbasierte Kryptowährungs-Mining- …
“It Won’t Be China That Takes Control — It’ll Be Musk”: Enrique Abeyta Says Trump’s AI Order Hands Elon the Reins of America’s Machine Future
GlobeNewswire
·
June 2, 2025
WASHINGTON, June 01, 2025 (GLOBE NEWSWIRE) -- Most headlines worry about foreign AI dominance. But former hedge fund manager Enrique Abeyta sees a different threat rising from within. Abeyta explains in his recent briefing that with Elon Musk’s AI …
Biognosys stellt Spectronaut 20 und SpectroMine 5 vor und setzt damit neue Maßstäbe in der Immunopeptidomik
GlobeNewswire
·
June 2, 2025
ZÜRICH und BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Biognosys, ein weltweit führender Anbieter von massenspektrometriebasierten Proteomiklösungen, gibt die Einführung von Spectronaut® 20 und SpectroMine™ 5 auf der ASMS 2025 Annual Conference bekannt, die …
Biognosys lanza Spectronaut 20 y SpectroMine 5, estableciendo un nuevo hito en la inmunopeptidómica
GlobeNewswire
·
June 2, 2025
ZÚRICH y BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Biognosys, líder mundial en soluciones de proteómica basadas en espectrometría de masas, ha anunciado el lanzamiento de Spectronaut® 20 y SpectroMine™ 5 en la convención anual ASMS de 2025, que tendrá …
Biognosys lance Spectronaut 20 et SpectroMine 5, établissant de nouvelles références en immunopeptidomique
GlobeNewswire
·
June 2, 2025
ZURICH et BOSTON, 02 juin 2025 (GLOBE NEWSWIRE) -- Biognosys, leader mondial des solutions de protéomique basées sur la spectrométrie de masse, annonce le lancement de Spectronaut® 20 et SpectroMine™ 5 lors de la conférence annuelle ASMS 2025, qui se …
Biognosys lancia Spectronaut 20 e SpectroMine 5 e stabilisce nuovi parametri di riferimento nell'immunopeptidomica
GlobeNewswire
·
June 2, 2025
ZURIGO e BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Biognosys, leader mondiale nelle soluzioni di proteomica basate sulla spettrometria di massa, annuncia il lancio di Spectronaut® 20 e SpectroMine™ 5 alla Conferenza annuale dell'American Society for Mass …
Biognosys zet toon in immunopeptidomics met Spectronaut 20 en SpectroMine 5
GlobeNewswire
·
June 2, 2025
ZURICH en BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Tijdens de ASMS 2025 Annual Conference, die van 1 tot 5 juni wordt gehouden in Baltimore, presenteert Biognosys, een internationale koploper in proteomica-oplossingen op basis van massaspectrometrie, …
HUTCHMED Highlights SACHI Phase III Study Data Presented at the 2025 ASCO Annual Meeting
GlobeNewswire
·
June 2, 2025
— The all-oral chemotherapy-free combination of savolitinib plus osimertinib demonstrated significant PFS benefit with a favorable safety profile in the SACHI Phase III China study — — Webcast to be held at 8:30 am HKT on Tuesday, June 3 to discuss the …